BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 23114130)

  • 1. [Curative efficiency of rituximab combined with autologous cytokine induced killer cells on aged patient with orbital diffuse large B cell lymphoma].
    Li SX; Zhu HL; Guo B; Lu XC; Fan H; Lin J; Yang B; Liu Y; Yang Y; Ran HH; Zhai B; Han WD; Wang Y; Yao SQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Oct; 20(5):1117-21. PubMed ID: 23114130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical study of autologous cytokine-induced killer cells for the treatment of elderly patients with diffuse large B-cell lymphoma.
    Lu XC; Yang B; Yu RL; Chi XH; Tuo S; Tuo CW; Zhu HL; Wang Y; Jiang CG; Fu XB; Yang Y; Liu Y; Yao SQ; Dai HR; Cai L; Li BJ; Han WD
    Cell Biochem Biophys; 2012 Jan; 62(1):257-65. PubMed ID: 21913005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Short-term curative efficacy of autologous cytokine induced killer cells combined with low-dose IL-2 regimen containing immune enhancement by thymic peptide in elderly patients with B-cell chronic lymphocytic leukemia].
    Cai LL; Yang Y; Yang B; Zhu HL; Lu XC; Zhang WY; Yu RL; Chi XH; Wang Y; Dai HR; Han WD; Fan H; Li SX; Liu Y; Ran HH; Lin J; Tuo S; Tuo CW; Zhang F; Cao JP; Yao SQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Jun; 20(3):564-70. PubMed ID: 22739156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical study of autologous cytokine induced killer cells combined with IL-2 for therapy of elderly patients with B-cell malignant lymphoma].
    Yang B; Lu XC; Zhu HL; Han WD; Wang Y; Fan H; Li SX; Liu Y; Dai HR; Yao SQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1244-9. PubMed ID: 21129269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical Analysis of Autologous Cytokine-induced Killer Cells Combined with IL-2 for Treating of Elderly Patients with B-cell Malignant Lymphoma].
    Wu Y; Shi L; Feng L; Lv DL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):738-43. PubMed ID: 27342501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeated transfusions of autologous cytokine-induced killer cells for treatment of haematological malignancies in elderly patients: a pilot clinical trial.
    Yang B; Lu XC; Yu RL; Chi XH; Liu Y; Wang Y; Dai HR; Zhu HL; Cai LL; Han WD
    Hematol Oncol; 2012 Sep; 30(3):115-22. PubMed ID: 22972689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Application of immune function test to evaluate effect of cytokine-induced autologous killer cell infusion for elderly patients with hematological malignancies].
    Cai LL; Yang B; Lu XC; Zhu HL; Han WD; Wang Y; Liu Y; Dai HR; Yao SQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1250-5. PubMed ID: 21129270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous cytokine-induced killer (CIK) cell immunotherapy combined with cyclophosphamide in five patients with POEMS syndrome.
    Ma L; Wang Y; Bo J; Han W; Wang Y; Zhang L; Wu X; Yu S; Liu R
    Clin Exp Immunol; 2016 Apr; 184(1):83-9. PubMed ID: 26660736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Combination of rituximab with autologous peripheral blood stem cell transplantation for treatment of diffuse large B-cell lymphoma: a single-center experience].
    Liang ZY; Cen XN; Qiu ZX; Ou JP; Wang WS; Xu WL; Li Y; Wang MJ; Dong YJ; Wang LH; Yin Y; Sun YH; Liu W; Wang Q; Ren HY
    Zhonghua Xue Ye Xue Za Zhi; 2012 Dec; 33(12):1033-7. PubMed ID: 23363798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autologous cytokine-induced killer cell therapy in lung cancer patients: a retrospective study.
    Zhang J; Zhu L; Du H; He X; Yin Y; Gu Y; Liu L; Lu K; Guo R; Liu P; Shu Y
    Biomed Pharmacother; 2015 Mar; 70():248-52. PubMed ID: 25776508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical study of autologous cytokine induced killer cells combined with chemotherapy for elderly patients with acute myeloid leukemia].
    Yang Y; Yang B; Cai LL; Ran HH; Yu RL; Chi XH; Zhu HL; Li SX; Liu Y; Wang Y; Han WD; Yao SQ; Lu XC
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Feb; 22(1):58-63. PubMed ID: 24598652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose therapy and autologous stem cell transplantation in first relapse for diffuse large B cell lymphoma in the rituximab era: an analysis based on data from the European Blood and Marrow Transplantation Registry.
    Mounier N; Canals C; Gisselbrecht C; Cornelissen J; Foa R; Conde E; Maertens J; Attal M; Rambaldi A; Crawley C; Luan JJ; Brune M; Wittnebel S; Cook G; van Imhoff GW; Pfreundschuh M; Sureda A;
    Biol Blood Marrow Transplant; 2012 May; 18(5):788-93. PubMed ID: 22005647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced killing of human B-cell lymphoma targets by combined use of cytokine-induced killer cell (CIK) cultures and anti-CD20 antibodies.
    Pievani A; Belussi C; Klein C; Rambaldi A; Golay J; Introna M
    Blood; 2011 Jan; 117(2):510-8. PubMed ID: 21048157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implication of different effector mechanisms by cord blood-derived and peripheral blood-derived cytokine-induced killer cells to kill precursor B acute lymphoblastic leukemia cell lines.
    Durrieu L; Lemieux W; Dieng MM; Fontaine F; Duval M; Le Deist F; Haddad E
    Cytotherapy; 2014 Jun; 16(6):845-56. PubMed ID: 24529554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy with or without autologous cytokine-induced killer cell transfusion as the first-line treatment for stage IV gastrointestinal cancer: a phase II clinical trial.
    Xu YC; Xu Q; Li JJ; Gu XF; Lin XL; Sun L; Lu HM; Tang L; Ma Y; Lu Z; Wang HX
    J Cancer Res Clin Oncol; 2016 Jun; 142(6):1315-23. PubMed ID: 26941189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma].
    Huang HQ; Bu Q; Xia ZJ; Lin XB; Wang FH; Li YH; Peng YL; Pan ZH; Wang SS; Lin TY; Jiang WQ; Guan ZZ
    Ai Zheng; 2006 Apr; 25(4):486-9. PubMed ID: 16613686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of lingdankang composite combined dendritic cell-cytokine induced killer cells in treating leukemia].
    Liu QC; Wu WH; Li GR
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2009 Apr; 29(4):347-50. PubMed ID: 19526763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective study of chemotherapy in combination with cytokine-induced killer cells in patients suffering from advanced non-small cell lung cancer.
    Wu C; Jiang J; Shi L; Xu N
    Anticancer Res; 2008; 28(6B):3997-4002. PubMed ID: 19192663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of prior rituximab on outcomes of autologous stem-cell transplantation in patients with relapsed or refractory aggressive B-cell lymphoma: a multicentre retrospective Spanish group of lymphoma/autologous bone marrow transplant study.
    Redondo AM; Pomares H; Vidal MJ; Pascual MJ; Quereda B; Sancho JM; Polo M; López J; Conde E; Jarque I; Alonso N; Ramírez MJ; Fernández P; Sayas MJ; Requena MJ; Salar A; González JD; González-Barca E; Arranz R; Caballero D; Martín A
    Br J Haematol; 2014 Mar; 164(5):668-74. PubMed ID: 24274082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical study of autologous cytokine induced killer cell infusion treating for elderly patients with myelodysplastic syndrome].
    Liu Y; Bao EN; Yang B; Lu XC; Zhu HL; Han WD; Wang Y; Dai HR; Yao SQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Jun; 19(3):787-92. PubMed ID: 21729572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.